Brief: XVIVO Receives Market Approval For STEEN Solution And XPS
April 29 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* SAID ON SATURDAY RECEIVED MARKET APPROVAL (PMA) FROM FDA
FOR
STEEN SOLUTION AND XPS
* RECEIVES PREMARKET APPROVAL (PMA) FROM FDA FOR PRODUCTS
XPS AND
STEEN SOLUTION FOR SALE ON THE AMERICAN MARKET
Source text for Eikon: urn:newsml:reuters.com:*:nWkr4Jsy41
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength